Jak1 Products
Jak1, Jak 2, and Jak3 belong to the Janus Kinases family of protein tyrosine kinases that couple to cytokine receptors once activated by their corresponding ligands. Activation of Jak family members occurs via phosphorylation at two adjacent tyrosine residues as well as potentially one or more serine residues. Jaks activate members of the STAT family of transcription factors by phosphorylating critical tyrosine regulatory sites.
Jak1 is required for the activation of STAT1 and STAT2 in response to interferon. Jak2 plays an essential role in interferon gamma signaling. Also known as Leukocyte Janus Kinase (LJak), Jak3 is activated after binding to the gamma chain of Interleukin receptors, specifically the IL-2 and IL-4 receptors. Activation of Jak3 is associated with the rapid tyrosine phosphorylation of STAT proteins. Defects in Jak3 cause an autosomal severe combined immunodeficiency disease (SCID).
45 results for "Jak1" in Products
45 results for "Jak1" in Products
Jak1 Products
Jak1, Jak 2, and Jak3 belong to the Janus Kinases family of protein tyrosine kinases that couple to cytokine receptors once activated by their corresponding ligands. Activation of Jak family members occurs via phosphorylation at two adjacent tyrosine residues as well as potentially one or more serine residues. Jaks activate members of the STAT family of transcription factors by phosphorylating critical tyrosine regulatory sites.
Jak1 is required for the activation of STAT1 and STAT2 in response to interferon. Jak2 plays an essential role in interferon gamma signaling. Also known as Leukocyte Janus Kinase (LJak), Jak3 is activated after binding to the gamma chain of Interleukin receptors, specifically the IL-2 and IL-4 receptors. Activation of Jak3 is associated with the rapid tyrosine phosphorylation of STAT proteins. Defects in Jak3 cause an autosomal severe combined immunodeficiency disease (SCID).
Reactivity: | Human, Mouse, Rat |
Details: | Rat IgG2b Monoclonal Clone #413104 |
Applications: | WB, Simple Western, IHC, ICC |
Reactivity: | Human, Mouse |
Details: | Mouse IgG2a Monoclonal Clone #452804 |
Applications: | WB, Simple Western |
Recombinant Monoclonal Antibody.
Reactivity: | Human, Mouse, Rat |
Details: | Rabbit IgG Monoclonal Clone #JM75-03 |
Applications: | IHC, WB, Flow |
Reactivity: | Mouse, Rat |
Details: | Goat IgG Polyclonal |
Applications: | WB, ICC |
Reactivity: | Human, Mouse, Rat |
Details: | Rabbit IgG Polyclonal |
Applications: | IHC, WB |
Applications: | ELISA |
Applications: | WB, ELISA, MA, AP |
Recombinant Monoclonal Antibody
Reactivity: | Human, Mouse, Rat |
Details: | Rabbit IgG Monoclonal Clone #7Q1B2 |
Applications: | IHC, WB |
Recombinant Monoclonal Antibody
Reactivity: | Human |
Details: | Rabbit IgG Monoclonal Clone #SR1138 |
Applications: | IHC, WB |
Reactivity: | Human, Mouse |
Details: | Rabbit IgG Polyclonal |
Applications: | WB, ICC/IF |
Recombinant monoclonal antibody expressed in HEK293F cells
Reactivity: | Human |
Details: | Rabbit IgG Monoclonal Clone #7A5 |
Applications: | IHC, ELISA |
Applications: | WB |
Reactivity: | Human, Mouse, Rat |
Details: | Rat IgG2B Monoclonal Clone #413104 |
Applications: | IHC, WB, ICC/IF, Flow, CyTOF-ready |
Reactivity: | Human, Mouse, Rat |
Details: | Rat IgG2B Monoclonal Clone #413104 |
Applications: | IHC, WB, ICC/IF, Flow, CyTOF-ready |
Reactivity: | Human, Mouse, Rat |
Details: | Rat IgG2B Monoclonal Clone #413104 |
Applications: | IHC, WB, ICC/IF, Flow, CyTOF-ready |
Reactivity: | Human, Mouse, Rat |
Details: | Rat IgG2B Monoclonal Clone #413104 |
Applications: | IHC, WB, ICC/IF, Flow, CyTOF-ready, +1 More |
Reactivity: | Human, Mouse, Rat |
Details: | Rat IgG2B Monoclonal Clone #413104 |
Applications: | IHC, WB, ICC/IF, Flow, CyTOF-ready, +1 More |
JAK1-selective inhibitor
Chemical Name: | (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide |
Purity: | ≥98% (HPLC) |
Potent and selective JAK1/JAK2 inhibitor; orally bioavailable
Alternate Names: | INCB018424 |
Chemical Name: | (3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile |
Purity: | ≥98% (HPLC) |
Highly potent JAK1 and JAK2 inhibitor; also inhibits JAK3 and Tyk2
Alternate Names: | INCB 28050 |
Chemical Name: | 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile |
Purity: | ≥98% (HPLC) |
Phosphate salt of Ruxolitinib (Cat. No. 7064); potent and selective JAK1/JAK2 inhibitor
Chemical Name: | (3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphate |
Purity: | ≥98% (HPLC) |
Potent JAK inhibitor
Alternate Names: | Tofacitinib citrate |
Chemical Name: | (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile citrate |
Purity: | ≥99% (HPLC) |
Potent pan-JAK inhibitor; induces intermediate mesoderm; cell-permeable
Alternate Names: | JAK inhibitor I |
Chemical Name: | 2-(1,1-Dimethylethyl)-9-fluoro-1,6-dihydro-7H-benz[h]imidazo[4,5-f]isoquinolin-7-one |
Purity: | ≥98% (HPLC) |
Potent and selective JAK2 inhibitor; antiangiogenic
Chemical Name: | 5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidine-2,4-diamine |
Purity: | ≥98% (HPLC) |